Evidence map›Paper›PMID 40590337›Full record

ArticleFuture science OA2025

Editorial for "a predictive model for irAEs in ESCC patients treated with PD-1 inhibitors based on blood indicators".

Yaser Soleimani, Seyedehhoda Khatibmasjedi, Seyed Alireza Javadinia, Sara Shenavaei Zare, Reza Chaman

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Future science OA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yaser SoleimaniMedical School, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0009-0000-3412-3277
Seyedehhoda KhatibmasjediPalliative care department, Case Western Reserve University, University Hospitals, Seidman Cancer Center, Cleveland, Ohio, USA.ORCID 0000-0002-3619-069X
Seyed Alireza JavadiniaNon-Communicable Diseases Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran.ORCID 0000-0003-2467-837X
Sara Shenavaei ZareCellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran.ORCID 0000-0002-7910-742X
Reza ChamanNon-Communicable Diseases Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran.ORCID 0000-0003-4486-8971

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

blood biomarkersEsophageal squamous cell carcinoma (ESCC)immune checkpoint inhibitorsimmune-related adverse events (irAEs)neutrophil-to-lymphocyte ratio (NLR)PD-1 inhibitorspredictive model

Identifiers

PMID40590337
PMCPMC12218414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.